Adipose News and Research

RSS

PI3 kinase boosts body heat, helps burn excess calories

New findings by UT Southwestern Medical Center researchers suggest that an enzyme in the brain known as PI3 kinase might control the increased generation of body heat that helps burn off excess calories after eating a high-fat meal.

7 Jul 2010

POMC neurons suppress appetite, induce weight loss: Research

A protein found in cells throughout the body must be present in a specific set of neurons in the brain to prevent weight gain after chronic feeding on high-calorie meals, new findings from UT Southwestern Medical Center researchers suggest.

7 Jul 2010

Data on MetAP2 inhibitors for treatment of obesity presented at ADA 2010

Zafgen, Inc., a pharmaceutical company pioneering novel obesity therapeutics to help the body regain and sustain a lean, healthy state by targeting imbalances in fat metabolism, today announced data on ZGN-201, a prototype methionine aminopeptidase 2 inhibitor, for the treatment of obesity. Preclinical studies demonstrate MetAP2 inhibition eliminates excess body weight through the regulation of fat metabolism and food intake, and normalizes glucose tolerance in animal models.

28 Jun 2010

Ethicon Endo-Surgery renews research collaboration agreement with UC and Metabolic Diseases Institute

Ethicon Endo-Surgery, Inc. (EES) today announced it has renewed its research collaboration agreement with the University of Cincinnati (UC) and its Metabolic Diseases Institute (MDI). The three-year, $13.5M grant extension, is part of the EES Metabolic Applied Research Strategy (MARS), which also includes research from GI Metabolism Laboratory and Weight Center at the Massachusetts General Hospital (MGH).

22 Jun 2010

First StemSource Cell Bank in U.S. open

BioLife Cell Bank, LLC has opened the first U.S. StemSource® Cell Bank, which offers patients a way to safely and affordably store their own adipose (fat) tissue or their own naturally occurring adipose (fat) tissue-derived stem and regenerative cells. This gives patients and physicians easy, multi-use access to cells and tissue for future approved or allowed reconstructive fat grafting or augmentation procedures using the patients' own cells and/or tissue.

21 Jun 2010

Encouraging interim results from stem and regenerative cell-enriched fat grafting breast reconstruction trial

Interim results from a breast reconstruction trial show stem and regenerative cell-enriched fat grafting resulted in a high sustained rate of physician and patient satisfaction and persistent improvements in overall outcomes of the procedure at six and 12 months.

18 Jun 2010

Life Technologies announces product launches in concert with ISSCR 8th Annual Meeting

Life Technologies Corporation, a provider of innovative life science solutions, today announced activities and product launches in concert with the International Society for Stem Cell Research (ISSCR) 8th Annual Meeting that highlight the company's offerings of complete end-to-end solutions for stem cell research. Stem cell research has been shown to be a critical component of regenerative medicine; a basis for identifying drug targets and drug screening; and an important step in the development of therapies to treat a variety of diseases.

18 Jun 2010

USPTO grants ISCO patent to International Stem Cell's hpSC

International Stem Cell Corporation, www.intlstemcell.com, announced today that the United States Patent and Trademark Office has granted ISCO patent number 7,732,202, the first of several pending patents relating to its development of human parthenogenetic Stem Cells. Human parthenogenetic stem cells are a new type of pluripotent stem cell that allows immune matching to potentially solve critical immune rejection problems, and does not involve the ethical issues that surround the use of fertilized human embryos.

8 Jun 2010

New technology involving adipose stem cells may one day cure patients with severe wounds: Researchers

New technology developed by University of Virginia inventors involving adipose stem cells - adult stem cells found in fatty tissue - could one day be used to treat patients with severe wounds and other serious conditions.

8 Jun 2010

Key regulator of fat cell differentiation identified

New research led by UCD Conway Fellow, Professor Johan Ericsson has identified a key regulator of fat cell differentiation that may be a novel target for obesity drugs. The results of the research are published in the current edition of the scientific journal, Proceedings of the National Academy of Sciences (PNAS).

4 Jun 2010

Bioheart to establish two Centers of Excellence to provide cell therapy procedures for patients with CHF, PAD

Bioheart, Inc., announced today plans for establishing two Centers of Excellence in the Middle East to provide its cell therapy procedures to patients suffering from congestive heart failure and peripheral arterial disease. Dr. Karl E. Groth, Chairman and CEO, and Peggy A. Farley, Chief Operating and Financial Officer, are now in that region holding discussions and performing site inspections.

29 May 2010

MicroStockProfit.com releases investment report on Cord Blood America

MicroStockProfit.com announces an investment report featuring Cord Blood America Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

28 May 2010

Low frequency ultrasound can heal and regenerate body tissues

When we think of ultrasound, it's usually imaging the inside of the body that springs to mind. However, while ultrasound imaging typically requires frequencies that are 50 to 2500 times higher than those human ear can detect, recent increasing evidence indicates that ultrasound at lower frequency can also be used to help certain body tissues to heal and regenerate. Now research that appears in Open Access Journal of Tissue Engineering published by SAGE-Hindawi suggests that ultrasound could also help tissue grafts to survive and thrive following surgery.

28 May 2010

Europe's leading stem cell bank launches innovative service for liposuction market

Cryo-Save today announced the European introduction of Cryo-Lip, a new product that allows the collection, processing and storage of a rich mixture of adult stem cells from liposuction aspirate (fatty tissue that is normally discarded).

24 May 2010

New technique may improve treatments for heart disease

Spanish researchers have employed for the first time adult cells extracted from a human heart to turn stem cells from adipose tissue into cardiac myocytes. In other words, they achieved to "reprogram" adult stem cells, which might improve treatments for heart disease therapeutical.

21 May 2010

Spanish researchers reprogram adult stem cells to help cardiac muscle regeneration

20 May 2010

Tengion reports net loss attributable to common stockholders of $14.33 per share for first-quarter 2010

Tengion Inc. today reported its financial results for the quarter ended March 31, 2010 and provided a corporate and clinical development update.

18 May 2010

Cytori's first StemSource Cell Bank sold in the U.S.

Cytori Therapeutics has sold its first StemSource Cell Bank in the United States. The StemSource Cell Bank is a suite of products that offers patients a way to store their own adipose tissue, or the stem and regenerative cells naturally occurring within their own adipose tissue, in an automated, affordable and safe manner.

18 May 2010

152 research and training grants awarded to researchers at 93 institutions nationwide

The American Cancer Society, the largest non-government, not-for-profit funding source of cancer research in the United States, has awarded 152 new national research and training grants totaling $50,717,000 in the first of two grants cycles for 2010. The grants, primarily to early career researchers, cover a broad range of investigator-initiated ideas at 93 institutions nationwide, from whether cadmium exposure increases the risk of endometrial cancer, to studies of plant and bacterial-bourne compounds, to a study on a protein called survivin that could lead to novel drugs targeting prostate cancer.

18 May 2010

Positive results from Cytori's Celution-based ADRC trial for treatment of no-option chronic heart disease patients

The first clinical trial of adipose (fat) tissue-derived stem and regenerative cells (ADRCs) for the treatment of no-option chronic heart disease patients showed the following: the procedure was safe and feasible; it demonstrated a statistically significant improvement in maximum oxygen consumption and patients' aerobic capacity measured as metabolic equivalents

10 May 2010

Adipose News and Research

PI3 kinase boosts body heat, helps burn excess calories

POMC neurons suppress appetite, induce weight loss: Research

Data on MetAP2 inhibitors for treatment of obesity presented at ADA 2010

Ethicon Endo-Surgery renews research collaboration agreement with UC and Metabolic Diseases Institute

First StemSource Cell Bank in U.S. open

Encouraging interim results from stem and regenerative cell-enriched fat grafting breast reconstruction trial

Life Technologies announces product launches in concert with ISSCR 8th Annual Meeting

USPTO grants ISCO patent to International Stem Cell's hpSC

New technology involving adipose stem cells may one day cure patients with severe wounds: Researchers

Key regulator of fat cell differentiation identified

Bioheart to establish two Centers of Excellence to provide cell therapy procedures for patients with CHF, PAD

MicroStockProfit.com releases investment report on Cord Blood America

Low frequency ultrasound can heal and regenerate body tissues

Europe's leading stem cell bank launches innovative service for liposuction market

New technique may improve treatments for heart disease

Spanish researchers reprogram adult stem cells to help cardiac muscle regeneration

Tengion reports net loss attributable to common stockholders of $14.33 per share for first-quarter 2010

Cytori's first StemSource Cell Bank sold in the U.S.

152 research and training grants awarded to researchers at 93 institutions nationwide

Positive results from Cytori's Celution-based ADRC trial for treatment of no-option chronic heart disease patients

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News